Krishnarup Ghoshdastidar, Hoshang Patel, Hitesh Bhayani, Ankit Patel, Kinjal Thakkar, Dinesh Patel, . . . Ranjit C. Desai. (2020). ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer. Wiley.
Chicago Style (17th ed.) CitationKrishnarup Ghoshdastidar, et al. ZYBT1, a Potent, Irreversible Bruton's Tyrosine Kinase (BTK) Inhibitor That Inhibits the C481S BTK with Profound Efficacy Against Arthritis and Cancer. Wiley, 2020.
MLA (9th ed.) CitationKrishnarup Ghoshdastidar, et al. ZYBT1, a Potent, Irreversible Bruton's Tyrosine Kinase (BTK) Inhibitor That Inhibits the C481S BTK with Profound Efficacy Against Arthritis and Cancer. Wiley, 2020.
Warning: These citations may not always be 100% accurate.